| __timestamp | Amicus Therapeutics, Inc. | AstraZeneca PLC |
|---|---|---|
| Wednesday, January 1, 2014 | 20717000 | 13324000000 |
| Thursday, January 1, 2015 | 47269000 | 11451000000 |
| Friday, January 1, 2016 | 71151000 | 9739000000 |
| Sunday, January 1, 2017 | 88671000 | 10543000000 |
| Monday, January 1, 2018 | 127200000 | 10362000000 |
| Tuesday, January 1, 2019 | 169861000 | 11848000000 |
| Wednesday, January 1, 2020 | 156407000 | 11693000000 |
| Friday, January 1, 2021 | 192710000 | 15680000000 |
| Saturday, January 1, 2022 | 213041000 | 18955000000 |
| Sunday, January 1, 2023 | 275270000 | 18025000000 |
Unlocking the unknown
In the ever-evolving pharmaceutical industry, understanding spending patterns is crucial. Over the past decade, AstraZeneca PLC and Amicus Therapeutics, Inc. have shown distinct trajectories in their Selling, General, and Administrative (SG&A) expenses. AstraZeneca, a global leader, consistently spent significantly more, with a peak in 2022 at approximately $18 billion, reflecting its expansive operations and market reach. In contrast, Amicus Therapeutics, a smaller biotech firm, demonstrated a steady increase, culminating in a 2023 expenditure of around $275 million, marking a 1,230% rise since 2014. This stark contrast highlights the scale and strategic priorities of each company. While AstraZeneca's spending underscores its global footprint, Amicus's growth in SG&A expenses signals its aggressive push into the market. These trends offer a window into the strategic maneuvers of pharmaceutical giants and emerging players alike.
Comparing SG&A Expenses: Merck & Co., Inc. vs AstraZeneca PLC Trends and Insights
SG&A Efficiency Analysis: Comparing AstraZeneca PLC and Bristol-Myers Squibb Company
AstraZeneca PLC or Bio-Techne Corporation: Who Manages SG&A Costs Better?
AstraZeneca PLC vs Viking Therapeutics, Inc.: SG&A Expense Trends
Comparing SG&A Expenses: AstraZeneca PLC vs PTC Therapeutics, Inc. Trends and Insights
Comparing SG&A Expenses: AstraZeneca PLC vs ImmunityBio, Inc. Trends and Insights
Intra-Cellular Therapies, Inc. and Amicus Therapeutics, Inc.: SG&A Spending Patterns Compared
Bio-Techne Corporation or Amicus Therapeutics, Inc.: Who Manages SG&A Costs Better?
SG&A Efficiency Analysis: Comparing PTC Therapeutics, Inc. and Amicus Therapeutics, Inc.
Operational Costs Compared: SG&A Analysis of MorphoSys AG and Amicus Therapeutics, Inc.
Amicus Therapeutics, Inc. and Soleno Therapeutics, Inc.: SG&A Spending Patterns Compared
SG&A Efficiency Analysis: Comparing Amicus Therapeutics, Inc. and Iovance Biotherapeutics, Inc.